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Abstract
Objectives—To develop a candidate definition for central line-associated blood stream infection 
(CLABSI) in neonates with presumed mucosal barrier injury due to gastrointestinal (MBI-GI) 
conditions; to evaluate epidemiology and microbiology of MBI-GI CLABSI in infants.
Design—Multicenter retrospective cohort study
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Setting—Neonatal intensive care units (NICU) from 14 U.S. children’s hospitals and pediatric 
facilities
Methods—A multidisciplinary focus group developed a candidate MBI-GI CLABSI definition 
based on presence of a MBI-GI condition, parenteral nutrition (PN) exposure, and an eligible 
enteric organism. CLABSI surveillance data from participating hospitals were supplemented by 
chart review to identify MBI-GI conditions and PN exposure.
Results—During 2009–12, 410 CLABSI occurred in 376 infants. MBI-GI conditions and PN 
exposure occurred in 149 (40%) and 324 (86%) of these 376 neonates, respectively. The 
distribution of pathogens was similar among neonates with versus without MBI-GI conditions and 
PN exposure. Fifty-nine (16%) of the 376 initial CLABSI episodes met the candidate MBI-GI 
CLABSI definition. Subsequent versus initial CLABSI were more likely to be caused by an 
enteric organism (22 of 34, 65% vs. 151 of 376, 40%; p = 0.009) and to meet the candidate MBI-
GI CLABSI definition (19 of 34, 56% vs. 59 of 376, 16%; p < 0.01).
Conclusions—While MBI-GI conditions and PN exposure were common, only 16% of initial 
CLABSI met the candidate definition of MBI-GI CLABSI. The high proportion of MBI-GI 
CLABSI among subsequent infections suggests infants with MBI-GI CLABSI should be a 
population targeted for further surveillance and interventional research.
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INTRODUCTION
Healthcare-associated infections (HAI) are responsible for increased morbidity, mortality, 
and utilization of health care resources. Bloodstream infections (BSI) are the most frequent 
type of HAI in pediatric patients.1 Recent efforts to prevent central line-associated BSI 
(CLABSI) have yielded significant reductions in many pediatric inpatient settings and 
institutions.2–5 However, as public reporting requirements expand and pay-for-performance 
strategies are implemented, clinicians and members of the hospital epidemiology community 
have expressed concern that not all CLABSI can be prevented by strict adherence to current 
CLABSI prevention bundles.6–9 Much of this concern has focused upon patients who are 
presumed to have disrupted integrity of mucosal barriers, particularly of the gastrointestinal 
(GI) tract. Many have hypothesized that translocation of colonizing bacteria across a 
damaged mucosal barrier, rather than introduction of bacteria along a percutaneous central 
venous catheter, may be a common mechanism of CLABSI in specific patient 
populations.10,11
In January 2013, a modified definition for laboratory-confirmed bloodstream infection was 
introduced by the National Healthcare Safety Network’s (NHSN).12 This new definition 
provides a mechanism to designate a BSI as related to mucosal barrier injury (MBI), 
provided both patient- and organism-specific criteria are met.10,11 Although there are scant 
empirical data to define the pathogenesis of these infections, this novel definition provides 
an opportunity to better understand CLABSI events in a specific, vulnerable patient 
population.
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Other patient populations with impaired intestinal mucosal barrier may also be at risk of BSI 
due to bacterial translocation. In pediatrics, patients with chronic intestinal dysfunction due 
to structural or functional abnormalities of the GI tract, such as congenital malformations or 
complications of prematurity, often have a prolonged need for parenteral nutrition (PN) and 
thus prolonged need for central venous catheterization. Anecdotal reports suggest that these 
patients may contribute disproportionately to the current CLABSI rates in institutions that 
have achieved marked success in CLABSI prevention among other patient populations.11 a 
We conducted this multicenter, retrospective cohort study to explore the epidemiology and 
microbiology of CLABSI in neonatal patients with and without chronic GI dysfunction.
METHODS
Participating Hospitals and Locations
Thirty-three children’s hospitals and pediatric facilities, which comprise the Pediatric 
Prevention EpiCenters Consortium, were invited to participate in this study. Of those, 14 
sites elected to participate, including 11 free-standing children’s hospitals. The study 
hospitals had a median of 288 beds and 3 infection preventionists. All participating sites 
performed surveillance for laboratory-confirmed BSI in neonatal intensive care unit (NICU) 
patients with central lines as part of their ongoing surveillance plans. Thirteen hospitals were 
in states that required public reporting of NICU CLABSI and at least 7 had undergone an 
external review of their CLABSI surveillance data. Each site obtained approval from their 
local Institutional Review Board.
Data Collection
Each site submitted 1–3 years of retrospective data (ranging from January 2009 through 
June 2012) on all episodes of laboratory-confirmed BSI in NICU patients with a central line 
at the time of infection onset. Only infections determined by the site to be a CLABSI by 
NHSN criteria13 were included in this analysis. Data collected for each event included 
patient age, month and year of infection, and organism(s) isolated. In addition, sites were 
asked whether the event was the patient’s initial or a subsequent event during the reporting 
period. For each event, study participants conducted chart review to determine the presence 
of any underlying GI condition(s) at the time of event, and whether PN and/or lipids had 
been administered during the 7 days prior to infection.
For each month during the data-reporting period, sites submitted the monthly number of 
NICU central line days.
Development of a Candidate Definition of a BSI related to MBI associated with a chronic GI 
condition
A focus group of neonatologists and pediatric gastroenterologists was convened to discuss 
the underlying conditions and clinical features of patients with GI conditions (other than 
those secondary to neutropenia or graft vs. host disease) that might be associated with an 
increased risk of bacteremia due to translocation. The following characteristics were 
identified as being associated with an increased risk of intestinal translocation: presence of ≥ 
1 specific GI conditions associated with MBI (MBI-GI conditions, Table 1) AND receipt of 
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PN ≤ 7 days prior to BSI. This timeframe was selected in recognition that some patients may 
receive lipid supplementation on a weekly basis and others may have had PN held due to 
temporary lack of venous access. We used organisms identified in the new NHSN MBI-
laboratory confirmed bloodstream infection definition12 as being eligible organisms for an 
MBI-GI event although viridans group streptococci were not included because they are 
considered oral commensal organisms (Table 1). Thus, a MBI-GI BSI was defined as 1) 
laboratory-confirmed bloodstream infection unrelated to another NHSN-defined infection/
process,13 2) in a patient with an eligible GI condition and PN exposure, and 3) caused by an 
eligible organism.
Classification of GI Conditions
Sites were asked to report all GI conditions that were present at the time of CLABSI onset 
from a pre-specified list of conditions (Table 1). For conditions not listed, free-text entry of 
other GI conditions was encouraged. For patients who had multiple GI conditions at the time 
of CLABSI onset, a hierarchy of conditions was created that assigned a primary GI 
condition. For patients who had both MBI-GI and non-MBI-GI conditions, the MBI-GI 
condition was assigned as the primary GI condition. For patients with multiple MBI-GI 
diagnoses, the condition with the presumed earliest onset was assigned as the primary GI 
condition. For patients with CLABSI and non-NHSN or non-acute NEC, we created an 
additional category of “non-NHSN NEC” which included: 1) a clinical syndrome of NEC 
that did not meet NHSN criteria (“suspected NEC”); 2) a history of NEC without reported 
complications (“past medical NEC”); and 3) a history of complicated NEC due to 
perforation or bowel resection (“past surgical NEC”).
Data Analysis
To understand differences between MBI-GI and non-MBI-GI CLABSI, our primary analysis 
focused on initial CLABSI events. Patient-level clinical and microbiologic data for CLABSI 
were summarized, with categorical data displayed as frequencies and percentages and 
continuous data described using medians and interquartile ranges. The pathogen mix of 
CLABSI from patients with and without MBI-GI conditions was compared using Pearson’s 
χ2 test and Fisher’s exact test, with a 2-tailed p value of <0.05 indicating statistical 
significance. Overall and site-specific monthly CLABSI rates (infections per 1000 catheter 
days) were calculated with and without inclusion of cases of MBI-GI CLABSI in the 
numerator. Analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).
RESULTS
Event Characteristics
A total of 410 CLABSI were reported from 376 NICU patients. Subsequent (n=34) CLABSI 
were excluded from the primary analysis of 376 initial CLABSI described below. At the 
time of initial CLABSI, most patients were < 30 days of age (Table 2).
GI Conditions and PN Exposure
One or more GI conditions were reported from 165 of 376 patients (44%) for a total of 282 
reported conditions, of which most (n=236, 84%) were MBI-GI conditions. The most 
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common non-MBI-GI conditions were intestinal perforation (n=19) and esophageal 
processes (n= 8). A total of 149 patients were found to have ≥1 MBI-GI conditions (Table 
3). The most prevalent GI condition among patients with initial CLABSI was non-NHSN 
NEC, including suspected NEC (n=20), past medical NEC (n=23), and past surgical NEC 
(n=37). At least 63 patients (17%) had undergone bowel resection. Most patients had recent 
PN exposure at the time of CLABSI (324 of 376, 86%), although PN was more common in 
patients with (139 of 149, 93%) than without MBI-GI conditions (185 of 227, 81%, p = 
0.0012).
Microbiology of CLABSI
Skin commensal organisms and S. aureus were the most commonly isolated organisms from 
patients with initial CLABSI. Enteric organisms, including Enterobacteriaceae (67) and 
Enterococcus spp. (43), were recovered from approximately one-third of patients with initial 
CLABSI, including 22 patients who had polymicrobial infections with at least one enteric 
organism. When the microbiology of initial CLABSI from patients with and without an 
eligible GI condition and PN exposure was compared, no significant differences were noted 
(Figure 1). NHSN MBI organisms were recovered from 59 of 139 CLABSI (42%) from 
patients with and 92 of 237 CLABSI (39%) from patients without an MBI-GI condition and 
PN exposure. Similarly, when the microbiology of CLABSI for patients with any as 
compared to no GI conditions was examined, no differences were observed (data not 
shown).
We examined the microbiology of CLABSI in patients with various specific GI conditions 
and noted no significant differences associated with specific GI conditions (Supplemental 
Table).
Classification of CLABSI
We identified 59 of 376 (16%) initial events that met the candidate definition of MBI-GI 
CLABSI. In contrast, 19 of 34 (56%) subsequent events were classified as MBI-GI CLABSI 
(p<0.05).
Patients with multiple CLABSI
There were a total of 34 subsequent CLABSI during the reporting period. These included 28 
patients with 2 CLABSI, 5 patients with 3 CLABSI and 1 patient with 4 CLABSI. Of the 28 
patients with more than 1 CLABSI, 17 (61%) had ≥ 1 MBI-GI condition, most commonly 
bowel resection (n=9), non-NHSN NEC (n=8), intestinal atresia (n=5) and gastroschisis 
(n=4). Eight (29%) patients had more than 1 MBI-GI condition, including 6 who had past 
surgical NEC. Twenty-four (86%) had recent PN exposure and 16 (57%) had both an 
eligible GI condition and recent PN exposure. NHSN MBI organisms were recovered from 
22 of 34 CLABSI (65%). When the microbiology of initial and subsequent CLABSI were 
compared, enteric organisms were more common in subsequent than initial infections (22 of 
34, 65% vs. 151 of 376, 40%; p = 0.009). Subsequent versus initial CLABSI were more 
likely to meet the candidate MBI-GI CLABSI definition (19 of 34, 56% vs. 59 of 376, 16%; 
p < 0.01).
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Impact of Candidate Definition on NICU CLABSI Rates
We determined the monthly CLABSI rates across all study sites with MBI-GI CLABSI both 
included and excluded from the numerator (Figure 2). Of 206 data months contributed by all 
sites, 140 months (68%) had no difference in monthly rates after removal of MBI-GI. We 
also examined the potential impact of removal of MBI-GI CLABSI from the monthly 
CLABSI rates of individual sites. We noted substantial differences across sites in the 
proportion of CLABSI meeting criteria for MBI-GI CLABSI (see Supplemental Figure).
DISCUSSION
In this multicenter cohort study of infants hospitalized in NICUs, we found that GI 
conditions were common and that approximately one-third of CLABSI occurred in infants 
with an MBI-GI condition and PN exposure. Contrary to our hypothesis, the distribution of 
organisms causing CLABSI was similar for patients with and without MBI-GI condition(s) 
and PN exposure. Sixteen percent of all NICU CLABSI met our proposed case definition of 
MBI-GI CLABSI, although the proportion of infections that fulfilled the criteria for this 
definition varied markedly by institution.
We found that 40% of infants with initial CLABSI had underlying GI conditions that were 
hypothesized to increase the risk of bacteremia due to translocation of enteric organisms 
across a chronically disrupted intestinal epithelium. NEC was the most prevalent GI 
condition, including past surgical NEC that was presumed to have led to “short bowel 
syndrome”. While our study design did not allow us to evaluate the relative risk of CLABSI 
among patients with and without various underlying GI conditions, the high prevalence of 
these conditions is consistent with prior reports that underlying GI conditions were a risk 
factor for CLABSI in both neonatal and older pediatric patients.14–1617, although this 
finding has not been universally observed.18
Enteric organisms were common causes of infection in our cohort and were isolated in 
approximately 40% of the reported CLABSI. Similarly, using data reported to the NHSN 
between 2006–2008, Hocevar and colleagues found that at least one-third of NICU CLABSI 
were due to an enteric organism.19 Bacteremia due to enteric organisms, particularly in 
patients with vascular devices, may arise from a variety of mechanisms. Translocation of 
organisms that colonize the intestinal tract has been hypothesized to be a mechanism of 
bacteremia. Studies performed in adult surgical patients in the 1990s demonstrated that 
enteric organisms were isolated from the mesenteric nodes of 14–21% of adult patients 
undergoing laparotomy20–22 and were associated with an increased risk of post-operative 
sepsis in one study.20 More recent studies of the intestinal microbiome in stem cell 
transplant patients suggested that “intestinal domination” by potentially pathogenic 
organisms was associated with markedly increased risk of bacteremia due to an enteric 
organism, presumably via translocation.23,24 Alternately, some episodes of bacteremia due 
to an enteric organism in patients with vascular catheters may arise from mechanisms related 
to the catheter. Hospitalized neonates can rapidly acquire both intestinal and cutaneous 
colonization with enteric organisms.25 Additionally, factors such as the presence of an 
ostomy or diarrhea might increase the likelihood of cutaneous colonization with enteric 
organisms. In the setting of suboptimal catheter care, these organisms could contaminate the 
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interior aspect of a needleless connector or migrate along the subcutaneous catheter tunnel 
and give rise to a CLABSI due to an enteric organism.26
Our a priori hypothesis was that CLABSI due to enteric organisms would be more prevalent 
among patients with an MBI-GI condition and PN exposures as compared to patients who 
did not have these characteristics. In this retrospective cohort, however, we observed that 
there was little difference in the pathogens that caused CLABSI in these two patient 
populations. Several major reasons might explain this observation. First, translocation might 
not be a common mechanism of bacteremia in patients with chronic GI conditions and PN 
dependence. In a report of findings from a successful multicenter collaborative to reduce 
NICU CLABSI, Schulman and colleagues found that despite significant reductions in the 
rate of CLABSI, the proportion of infections due to enteric organisms remained unchanged: 
34% prior to and 32% after implementation of a prevention bundle.5 This finding suggests 
that the bundle of interventions, all of which focused on insertion or maintenance of the 
catheter, had a similar impact on both CLABSI caused by skin organisms and CLABSI 
caused by enteric organisms. Presumably, enhanced care of a vascular catheter would not 
alter the risk of bacteremia due to translocation of organisms across a damaged intestinal 
epithelium.
Alternatively, misclassification bias might have masked possible differences in the 
microbiology of CLABSI between patients with and without chronic GI conditions and PN 
dependence. Although our candidate definition was derived by experienced clinicians who 
care for children with short bowel syndrome, it is unknown if this proposed surveillance 
definition is able to accurately identify infants with impaired integrity of their intestinal 
epithelial barrier. Our study design did not allow us to capture data on total duration of PN 
or to assess intestinal permeability, both characteristics of infants with intestinal failure.27,28 
Additionally, we were unable to measure other recognized risk factors for CLABSI, such as 
number and location of central lines, that might confound this observation. Thus, our study 
was unable to examine potential differences in the microbiology among patients with 
varying degrees of intestinal dysfunction. Additionally, the retrospective nature of our study 
might have limited our ability to capture accurately the complex GI conditions of our cohort. 
Our study was also significantly limited by the use of existing data from infection control 
departments. For example, misclassification bias may also have been introduced by our need 
to omit events previously designated as secondary BSI from this analysis because we lacked 
the resources needed to re-adjudicate these events. Therefore, we were unable to assess 
whether patients with GI conditions were at increased risk of CLABSI or to determine other 
risk factors for CLABSI such as catheter type and location. Finally, this study may have 
limited generalizability because all participating sites were academic level IV NICUs. Even 
within our study sites, there were may have been significant differences in the populations 
served (e.g. high proportion of term infants referred for surgical conditions) that led to the 
observed differences in the proportion of CLABSI that might be designated as MBI-GI 
CLABSI. Alternatively, there may have been important differences in the way lab-
confirmed BSI in patients with chronic GI conditions were classified (ie. as secondary BSI 
or CLABSI) or important practice differences at some hospitals that were successful in 
preventing CLABSI in this patient population.
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We identified an increased prevalence of enteric organisms in infants with MBI-GI 
condition(s) and PN exposure who experienced multiple CLABSI, an observation that might 
be consistent with translocation-related CLABSI. Similarly, a study from a national neonatal 
network reported that recurrent bloodstream infections were common among very low birth 
weight infants with intestinal failure, although skin flora were recovered from nearly half of 
the infections.29 Future initiatives might focus on the development of an “enteric CLABSI 
prevention bundle” that could be selectively applied to infants with chronic GI conditions 
and PN dependence who develop an initial CLABSI due to an enteric organism.
In summary, we developed a candidate definition for MBI BSI that may be used to identify a 
high-risk patient population with chronic underlying GI conditions associated with an 
increased risk of recurrent CLABSI. We observed that the microbiology of CLABSI among 
patients with chronic GI conditions and PN dependence who experienced multiple events 
was distinct from that observed for patients who did not have underlying GI conditions. 
Larger scale evaluation of this definition is needed to determine its capacity to differentiate 
BSI more likely to arise from translocation from CLABSI that likely arose related to routine 
care of a central venous catheter. This definition might be used to evaluate enhanced 
CLABSI prevention bundles in this high-risk patient population.
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Microbiology of initial CLABSI reported from 376 NICU patients with (panel A) and 
without (panel B) an MBI-GI condition and recent PN exposure. *Poly Enteric = 
polymicrobial infection that included one or more MBI enteric organisms; *Poly Non-
Enteric = polymicrobial infection that did not include any MBI enteric organisms.
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Aggregate monthly CLABSI rate with all CLABSI (green) and non-MBI-GI CLABSI (red) 
included.
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Table 1
Criteria for Candidate Definition of Mucosal-barrier Injury associated Gastrointestinal Insufficiency Event
Patient Factors Underlying Intestinal Condition Autoimmune enteropathy














Evidence of Intestinal Insufficiency Receipt of PN within 7 days prior to onset of infection
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Table 2
Patient characteristics at time of initial CLABSI (n = 376)
Characteristic Number (%)
Sex
 Male 217 (58)
Age
 < 30 days 195 (52)
 30–60 days 80 (21)
 61–90 days 39 (11)
 91 days to 6 months 46 (12)
 > 6 months 16 (4)
PN^ exposure within prior 7 days 324 (86)
Gastrointestinal (GI) condition
 Single MBI-GI condition 87 (23)
 >1 MBI-GI conditions 62 (17)
 Other GI condition 16 (4)
 None 211 (56)




intestinal insufficiency defined as the presence of an MBI-GI qualifying condition and PN exposure within 7 days prior to CLABSI
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Table 3
Final categorization of gastrointestinal conditions for 376 NICU patients
Final GI Categories by Patient N (%)
Non-NHSN NEC* 80 (21.3)
Gastroschisis/omphalocele w/ or w/o resection 31 (8)
Intestinal atresias w/ or w/o resection 16 (4)
Bowel resection 15 (4)
Motility disorder 6 (2)
Inflammatory bowel disease w/bowel resection 1 (0.3)
Extra-intestinal, intra-abdominal 9 (2.4)
Other intestinal 7 (2)
None 211 (56)
*
Non-NHSN NEC (necrotizing enterocolitis) included suspected NEC, past medical NEC and past surgical NEC
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